We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXR icon
301
Extra Space Storage
EXR
$32.3B
$32.2M 0.05%
247,473
+4,180
+2% +$570K
BR icon
302
Broadridge
BR
$18.4B
$32.1M 0.05%
143,877
+5,166
+4% +$1.18M
ATAT icon
303
Atour Lifestyle Holdings
ATAT
$4.81B
$32.1M 0.05%
814,537
-93,487
-10% -$3.66M
STT icon
304
State Street
STT
$48.4B
$32M 0.05%
248,305
-7,205
-3% -$863K
EOG icon
305
EOG Resources
EOG
$77.7B
$32M 0.05%
304,607
-6,478
-2% -$696K
VMC icon
306
Vulcan Materials
VMC
$36.8B
$31.8M 0.05%
111,473
-1,801
-2% -$528K
NUE icon
307
Nucor
NUE
$58.3B
$31.6M 0.05%
193,541
-2,062
-1% -$310K
TTWO icon
308
Take-Two Interactive
TTWO
$46.1B
$31.5M 0.05%
122,927
+4,417
+4% +$1.1M
CP icon
309
Canadian Pacific Kansas City
CP
$81B
$31.5M 0.05%
427,225
+37,987
+10% +$2.8M
CRNX icon
310
Crinetics Pharmaceuticals
CRNX
$8.88B
$31.4M 0.05%
674,533
+334,584
+98% +$14.9M
ELF icon
311
e.l.f. Beauty
ELF
$4.77B
$31.3M 0.05%
411,985
+30,409
+8% +$2.99M
NVO
312
Novo Nordisk
NVO
$228B
$31.3M 0.05%
614,866
+429,351
+231% +$22M
NDAQ icon
313
Nasdaq
NDAQ
$53.4B
$31.2M 0.05%
321,602
-2,494
-0.8% -$224K
CYTK icon
314
Cytokinetics
CYTK
$10.6B
$30.7M 0.05%
483,061
-444,771
-48% -$27.7M
LMT icon
315
Lockheed Martin
LMT
$131B
$30.7M 0.05%
63,410
+10,340
+19% +$4.95M
LSCC icon
316
Lattice Semiconductor
LSCC
$16B
$30.4M 0.05%
412,670
+6,080
+1% +$433K
IRM icon
317
Iron Mountain
IRM
$35.9B
$30.3M 0.05%
364,889
-17,745
-5% -$1.66M
IMVT icon
318
Immunovant
IMVT
$7.93B
$30.1M 0.05%
1,184,122
+202,318
+21% +$4.51M
BOOT icon
319
Boot Barn
BOOT
$4.58B
$30.1M 0.05%
170,443
+22,738
+15% +$4.24M
GIS icon
320
General Mills
GIS
$20.2B
$30M 0.05%
644,272
-8,591
-1% -$408K
SMA
321
SmartStop Self Storage REIT
SMA
$1.93B
$29.9M 0.05%
966,936
+149,391
+18% +$5.05M
TRGP icon
322
Targa Resources
TRGP
$56.8B
$29.7M 0.05%
161,156
+5,443
+3% +$917K
MDB icon
323
MongoDB
MDB
$25.8B
$29.4M 0.05%
70,001
-886
-1% -$322K
EYPT icon
324
EyePoint Inc
EYPT
$999M
$29.3M 0.05%
1,605,984
+809,182
+102% +$11.5M
FISV
325
Fiserv Inc
FISV
$29.7B
$29.3M 0.05%
435,590
-3,029
-0.7% -$254K

Similar funds

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.